ZYTO Announces Trading Symbol Change to "ZYTO"


LINDON, UT--(Marketwire - Aug 21, 2012) - ZYTO Corp (OTCBB: ZYTC) (www.ZYTO.com). 

ZYTO Corp, a Utah-based biotech company specializing in biocommunication applications, today announced that effective August 22, 2012, the Company's trading symbol for its stock, trading on the OTC Bulletin Board, will change from "ZYTC" to ZYTO".

"The new ZYTO ticker symbol aligns our stock symbol with the strong brand name we have developed," said Chairman and Chief Executive Officer, Dr. Vaughn R Cook. "The investing community and our customers know us as ZYTO."

"Our new trading symbol is another positive step in moving our company forward and building consistency," said Kami J. Howard, President and COO. "Please update your watch lists and portfolios with our new symbol."

About ZYTO Corp

ZYTO Corp was founded by its CEO Dr. Vaughn R Cook, OMD. The company designs and builds computer biocommunication technology to facilitate decision making about healthcare and wellness options.

For more information and to receive a copy of the Company's Quarterly Report, visit www.ZYTO.com or contact their Headquarters at 801-224-7199.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO's marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO's stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports filed with the U.S. Securities and Exchange Commission. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.

Contact Information:

ZYTO Corp
www.ZYTO.com
801-224-7199